Patents for C12R 1 - Micro-organisms (92,025)
07/2001
07/04/2001EP1112386A1 Improved microbial catalyst for desulfurization of fossil fuels
07/04/2001EP1112382A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes
07/04/2001EP1112372A1 Alternatively targeted adenovirus
07/04/2001EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization
07/04/2001EP1112359A2 Enhanced functional expression of g protein-coupled receptors
07/04/2001EP1112353A2 Recombinant protein production in urine
07/04/2001EP1112350A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
07/04/2001EP1112344A2 Bacterial strains for the production of 2-keto-l-gulonic acid
07/04/2001EP1112285A1 Human chordin-related proteins and polynucleotides encoding them
07/04/2001EP1112246A1 Microbial process for the preparation of acetic acid as well as solvents for its extraction from the fermentation broth
07/04/2001EP1112081A1 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
07/04/2001EP1112078A2 New use
07/04/2001EP1111991A1 Method of performing transgenesis
07/04/2001EP0679187B2 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv
07/04/2001CN1068047C Method for producing protease
07/03/2001US6255563 Nucleotide sequences coding enzymatic protein for reducing or preventing branching in plants
07/03/2001US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor
07/03/2001US6255115 Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
07/03/2001US6255107 An antibody reacting with a cell surface antigen expressed on tryptase and chymase positive human mast cells; treatment of allergic disease, bronchial asthma, allergic rhinitis
07/03/2001US6255100 Cyclosporin fermentation process
07/03/2001US6255098 A bacillus culture for the production of phytase enzyme for use with monogastric animals feed; prevent envirnomental pollution in water sources
07/03/2001US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities
07/03/2001US6255094 A nucleic acid encoding a protein; for large quantity production of sialyltransferase
07/03/2001US6255093 Recombinant microbial 3-hydroxybutyrate dehydrogenase a process for its production and the use thereof
07/03/2001US6255092 Stereospecific alcohol dehydrogenase isolated from Candida parapsilosis, amino acid and DNA sequences therefor, and method of preparation thereof
07/03/2001US6255076 Generating preferential protein in culture; culture genetically engineered bacteria, isolate protein form nutrients
07/03/2001US6255067 cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
07/03/2001US6254875 Methods for use of OMP26 from Haemophilus influenzae
07/03/2001US6254867 Human monoclonal antibodies to the hepatitis B surface antigen
07/03/2001US6254864 Methods and formulations for control of pests
07/03/2001CA2009508C Pf 1022 substance, method of producing same and anthelmintic composition containing same
06/2001
06/28/2001WO2001046390A2 Method of inactivating microorganisms
06/28/2001WO2001045721A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin
06/28/2001WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines
06/28/2001WO2001003647A3 Microbial process for preparing pravastatin
06/28/2001WO2000078927A3 Spheroid preparation
06/28/2001WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
06/28/2001WO2000077186A3 Bacterial protection against stress
06/28/2001WO2000075305A3 Candida albicans genes and proteins coded by said genes
06/28/2001WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
06/28/2001WO2000066731A3 Recombinant laminin 5
06/28/2001WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/28/2001WO2000055194A3 Tuberculosis antigens and methods of use therefor
06/28/2001WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same
06/28/2001WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses
06/28/2001DE19960843A1 Wurzelspezifischer Promotor Root-specific promoter
06/28/2001DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors
06/28/2001CA2329676A1 Salmonella vaccine
06/27/2001EP1111062A1 Nucleotide sequences encoding the gene zwa1
06/27/2001EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
06/27/2001EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
06/27/2001EP1111048A2 Neutral amino acid transporter and gene thereof
06/27/2001EP1110555A1 Antiadhesive agent for the pathogen flora of the skin
06/27/2001EP1109928A1 Enzymatic oxidative deamination process
06/27/2001EP1109922A1 Method for the production of heterologous polypeptides in transformed yeast cells
06/27/2001EP1109915A1 Nucleotide sequences for the tal gene
06/27/2001EP1109913A1 Nucleotide sequences which code for the opca gene
06/27/2001EP1109908A2 Leptin induced genes
06/27/2001EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
06/27/2001EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
06/27/2001EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin
06/27/2001EP1109892A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors
06/27/2001EP1109890A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique
06/27/2001EP1109829A1 Human latent transforming growth factor beta binding protein 3
06/27/2001EP1109820A1 Nocathiacin antibiotic derivatives prepared by microbial biotransformation
06/27/2001EP1109805A1 Inhibitors of bacterial nad synthetase
06/27/2001EP1109578A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
06/27/2001EP1109570A2 Method of modulating memory effector t-cells and compositions
06/27/2001EP1109454A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
06/27/2001EP0759066B1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof
06/27/2001EP0725800B1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE
06/27/2001EP0629131B1 Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens
06/27/2001EP0572454B1 Process for the preparation of 29-desmethylrapamycin and its use as antifungal or immunosuppressant agent
06/27/2001CN1301310A Method for producing hydroxycarboxylic acids by auto-degradation of polyhydroxyalkanoates
06/27/2001CN1301307A Methods for producing polypeptides in filamentous fungal mutant cells
06/27/2001CN1301303A Improved i(in vivo) production of cephalosporins
06/27/2001CN1301302A Gene encoding labyrinthin, a marker for cancer
06/27/2001CN1301301A I (vibrio cholerae) vaccine candidates and method of their constructing
06/27/2001CN1067726C Monoclonal antibody for recognizing interstitial cell surface antigen
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6252112 Process for the preparation of an enantiomer of a (1R, 4S) or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative
06/26/2001US6252046 Protein for the treatment of kidney defects
06/26/2001US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells
06/26/2001US6251885 Treating microorganism infection, lung cancer, breast cancer or leukemia in mammal
06/26/2001US6251877 Topically administering to individual composition comprising purified beta-1,6-branched-beta-1,3-glucan from schizophyllum commune in amount effective to cause proliferation of skin cells
06/26/2001US6251871 Administering pharmaceutical composition comprising adenoviral vector comprising promoter functional in eukaryotic cells and nucleic acid encoding p16 and buffer, solvent or diluent to mammal to inhibit tumor growth
06/26/2001US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases
06/26/2001US6251655 Dna sequence of phenylacetyl-coenzyme a ligase; recombinant culture production
06/26/2001US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies
06/26/2001US6251650 Pseudomonas putida amidase polypeptide useful for the production of chiral amides and acids
06/26/2001US6251649 Thermostable flap endonuclease derived from a hyperthermophile bacterium belonging to the genus pyrococcus
06/26/2001US6251646 Adding inorganic carbonate or bicarbonate salts to aqueous suspension of immobilized or nonimmobilized microbial cells
06/26/2001US6251636 Recombinant oleandolide polyketide synthase
06/26/2001US6251626 Generating enzymatic polypeptide; insert expression vector into cell, culture cells, recover enzymatic polypeptide
06/26/2001US6251613 Method for detecting anti-GADII antibody and method for diagnosing cancer using said detection method
06/26/2001US6251612 Hybridoma; cheap and sensitive monitoring of water pollution
06/26/2001US6251593 Regulatory sequences which are induced by maltose; for use in development of fungicides; for use in control of cell propagation
06/26/2001US6251585 Assay and reagents for identifying anti-proliferative agents
06/26/2001US6251422 Polyglutamic acid
06/26/2001US6251406 Attenuated microorganism strains and their uses